|
KMID : 1141720180060010033
|
|
폐쇄성폐질환
2018 Volume.6 No. 1 p.33 ~ p.38
|
|
|
|
|
Kim Min-Hye
|
|
|
Abstract
|
|
|
|
Allergen-specific immunotherapy is the only treatment that can change the disease course of allergic asthma. Recent meta-analysis studies have reported that immunotherapy is effective in reducing asthma symptoms and medication scores. In addition, severe reactions were extremely rare and most of reactions were mild or moderate which were self-limited or easily managed in terms of side effects, especially with the sublingual immunotherapy. As a result, sublingual immunotherapy is also recommended as a choice of additional therapy in the updated Global Initiative for Asthma guideline 2017. Although there is still a need for more studies using common indicators of asthma control and disease-specific quality of life, the results until now suggest that immunotherapy has already proved its efficacy and the potential to immune tolerance. Therefore, we can consider immunotherapy more actively in the treatment of asthma.
|
|
|
KEYWORD
|
|
|
Asthma, Allergy and immunology, Immunotherapy, Allergens, Sublingual immunotherapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|